Autonomix Medical, Inc. Common Stock
AMIX Real Time Price USDRecent trades of AMIX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by AMIX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
Estimated quarterly lobbying spending
AMIX Revenue by Segment or Geography
New patents grants
-
Patent Title: Controlled sympathectomy and micro-ablation systems and methods Mar. 25, 2025
-
Patent Title: Medical devices with circuitry for capturing and processing physiological Feb. 04, 2025
-
Patent Title: Elongated conductors and methods of making and using the same Aug. 27, 2024
-
Patent Title: Systems and methods for treating cancer and/or augmenting organ function Aug. 20, 2024
-
Patent Title: Endoscopic sympathectomy systems and methods Aug. 06, 2024
-
Patent Title: Systems, methods, and devices for monitoring and treatment of tissues within and/or through a lumen wall Jun. 18, 2024
-
Patent Title: Ans assessment systems, kits, and methods Jan. 30, 2024
-
Patent Title: Medical devices with circuitry for capturing and processing physiological signals Dec. 19, 2023
-
Patent Title: Systems and methods for neurological traffic and/or receptor functional evaluation and/or modification Feb. 28, 2023
-
Patent Title: Devices, systems, and methods for diagnosis and treatment of overactive bladder Jan. 31, 2023
-
Patent Title: Medical devices with circuitry for capturing and processing physiological signals Dec. 06, 2022
-
Patent Title: Systems and methods for regulating organ and/or tumor growth rates, function, and/or development Oct. 25, 2022
-
Patent Title: Elongated conductors and methods of making and using the same Sep. 20, 2022
-
Patent Title: Systems and methods for treating cancer and/or augmenting organ function Jul. 12, 2022
-
Patent Title: Endoscopic sympathectomy systems and methods May. 31, 2022
-
Patent Title: Systems and methods for treating cancer and/or augmenting organ function Mar. 15, 2022
-
Patent Title: Controlled and precise treatment of cardiac tissues Oct. 26, 2021
-
Patent Title: Controlled sympathectomy and micro-ablation systems and methods May. 25, 2021
-
Patent Title: Systems, methods, and devices for monitoring and treatment of tissues within and/or through a lumen wall Feb. 02, 2021
-
Patent Title: Smart torquer and methods of using the same Dec. 29, 2020
-
Patent Title: Elongated conductors and methods of making and using the same Dec. 22, 2020
-
Patent Title: Ans assessment systems, kits, and methods Oct. 06, 2020
-
Patent Title: Systems and methods for neurological traffic and/or receptor functional evaluation and/or modification Sep. 08, 2020
-
Patent Title: Systems and methods for regulating organ and/or tumor growth rates, function, and/or development Jun. 09, 2020
-
Patent Title: Elongated conductors and methods of making and using the same Nov. 26, 2019
-
Patent Title: Controlled sympathectomy and micro-ablation systems and methods Nov. 12, 2019
-
Patent Title: Systems and methods for regulating organ and/or tumor growth rates, function, and/or development Jul. 30, 2019
-
Patent Title: Elongated conductors and methods of making and using the same Mar. 26, 2019
-
Patent Title: Endoscopic sympathectomy systems and methods Mar. 12, 2019
-
Patent Title: Devices, systems, and methods for diagnosis and treatment of overactive bladder Feb. 19, 2019
-
Patent Title: Systems and methods for treating cancer and/or augmenting organ function Dec. 04, 2018
-
Patent Title: Systems and methods for treating cancer and/or augmenting organ function Nov. 27, 2018
-
Patent Title: Elongated conductors and methods of making and using the same Oct. 09, 2018
-
Patent Title: Controlled sympathectomy and micro-ablation systems and methods Jul. 17, 2018
-
Patent Title: Systems and methods for neurological traffic and/or receptor functional evaluation and/or modification Jun. 26, 2018
-
Patent Title: Endoscopic sympathectomy systems and methods May. 15, 2018
-
Patent Title: Systems, methods, and devices for monitoring and treatment of tissues within and/or through a lumen well May. 01, 2018
-
Patent Title: Elongated conductors and methods of making and using the same Aug. 15, 2017
-
Patent Title: Controlled sympathectomy and micro-ablation systems and methods May. 16, 2017
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to AMIX
Recent picks made for AMIX stock on CNBC
ETFs with the largest estimated holdings in AMIX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $AMIX stock a Buy, Sell, or Hold?
- What is the price target for $AMIX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $AMIX stock?
- Who owns the most shares of $AMIX stock?
- What funds own $AMIX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view AMIX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.